IL1RL1 and breast carcinoma: In a 4T1 breast cancer mouse model, IL-33/ST2 axis could not only reduce NK cell cytotoxicity, but also recruit immunosuppressive cells (MDSCs and Tregs) and ST2+ ILC2s to accumulate in tumors (81).